Developing New Antibiotics: What's the Best Approach to Take?


Daniel Pilch, PhD, discusses the approach that he and his team took to develop a new drug to fight MRSA.

Daniel Pilch, PhD, associate professor in the Department of Pharmacology at Rutgers Robert Wood Johnson Medical School, co-founder of TAXIS Pharmaceuticals, discusses the three choices that developers have when it comes to the approach they can take for developing a new antibiotic. Dr. Pilch shares the two areas in which he and his team's approach to treating drug-resistant bacteria has been focused.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.